Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck.

Ward MC, Lee NY, Caudell JJ, Zajichek A, Awan MJ, Koyfman SA, Dunlap NE, Zakem SJ, Hassanzadeh C, Marcrom S, Boggs DH, Isrow D, Vargo JA, Heron DE, Siddiqui F, Bonner JA, Beitler JJ, Yao M, Trotti AM, Riaz N; Multi-Institution Re-Irradiation (MIRI) Collaborative.

Oral Oncol. 2019 Mar;90:80-86. doi: 10.1016/j.oraloncology.2019.01.022. Epub 2019 Feb 8.

PMID:
30846182
2.

Proliferation saturation index in an adaptive Bayesian approach to predict patient-specific radiotherapy responses.

Sunassee ED, Tan D, Ji N, Brady R, Moros EG, Caudell JJ, Yartsev S, Enderling H.

Int J Radiat Biol. 2019 Mar 4:1-6. doi: 10.1080/09553002.2019.1589013. [Epub ahead of print]

PMID:
30831050
3.

Novel Genomic-Based Strategies to Personalize Lymph Node Radiation Therapy.

Oliver DE, Mohammadi H, Figura N, Frakes JM, Yamoah K, Perez BA, Wuthrick EJ, Naghavi AO, Caudell JJ, Harrison LB, Torres-Roca JF, Ahmed KA.

Semin Radiat Oncol. 2019 Apr;29(2):111-125. doi: 10.1016/j.semradonc.2018.11.003. Review.

PMID:
30827449
4.

Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience.

Oliver DE, Sondak VK, Strom T, Zager JS, Naghavi AO, Sarnaik A, Messina JL, Caudell JJ, Trotti AM, Torres-Roca JF, Khushalani NI, Harrison LB.

Melanoma Manag. 2018 Apr 9;5(1):MMT02. doi: 10.2217/mmt-2017-0025. eCollection 2018 Jun.

5.

Patient choice for high-volume center radiation impacts head and neck cancer outcome.

Naghavi AO, Echevarria MI, Strom TJ, Abuodeh YA, Venkat PS, Ahmed KA, Demetriou S, Frakes JM, Kim Y, Kish JA, Russell JS, Otto KJ, Chung CH, Harrison LB, Trotti A, Caudell JJ.

Cancer Med. 2018 Oct;7(10):4964-4979. doi: 10.1002/cam4.1756. Epub 2018 Sep 2.

6.

Temporally feathered intensity-modulated radiation therapy: A planning technique to reduce normal tissue toxicity.

López Alfonso JC, Parsai S, Joshi N, Godley A, Shah C, Koyfman SA, Caudell JJ, Fuller CD, Enderling H, Scott JG.

Med Phys. 2018 Jul;45(7):3466-3474. doi: 10.1002/mp.12988. Epub 2018 Jun 8.

PMID:
29786861
7.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.

PMID:
29752322
8.

Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation Dose.

Ahmed KA, Scott JG, Arrington JA, Naghavi AO, Grass GD, Perez BA, Caudell JJ, Berglund AE, Welsh EA, Eschrich SA, Dilling TJ, Torres-Roca JF.

J Thorac Oncol. 2018 Aug;13(8):1121-1127. doi: 10.1016/j.jtho.2018.04.027. Epub 2018 May 5.

PMID:
29733909
9.

Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis.

Caudell JJ, Ward MC, Riaz N, Zakem SJ, Awan MJ, Dunlap NE, Isrow D, Hassanzadeh C, Vargo JA, Heron DE, Marcrom S, Boggs DH, Reddy CA, Dault J, Bonner JA, Higgins KA, Beitler JJ, Koyfman SA, Machtay M, Yao M, Trotti AM, Siddiqui F, Lee NY; Multi-Institution Reirradiation (MIRI) Collaborative.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):606-617. doi: 10.1016/j.ijrobp.2017.11.036. Epub 2017 Dec 1.

PMID:
29413274
10.

More Information Needed, Surgery Provides It.

Otto KJ, Caudell JJ.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1061-1062. doi: 10.1016/j.ijrobp.2017.08.016. Epub 2017 Aug 24. No abstract available.

PMID:
29165274
11.

A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.

Vargo JA, Ward MC, Caudell JJ, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Higgins KA, Hassanadeh C, Beitler JJ, Reddy CA, Marcrom S, Boggs DH, Bonner JA, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, Ferris RL, Heron DE.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):595-605. doi: 10.1016/j.ijrobp.2017.04.017. Epub 2017 Apr 24.

PMID:
28899556
12.

Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative.

Ward MC, Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Vargo JA, Heron DE, Higgins KA, Beitler JJ, Marcrom S, Boggs DH, Hassanzadeh C, Reddy CA, Bonner JA, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA; Multi-Institution Reirradiation (MIRI) Collaborative.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):586-594. doi: 10.1016/j.ijrobp.2017.06.012. Epub 2017 Jun 17.

PMID:
28865925
13.

Predicting Patient-Specific Radiotherapy Protocols Based on Mathematical Model Choice for Proliferation Saturation Index.

Poleszczuk J, Walker R, Moros EG, Latifi K, Caudell JJ, Enderling H.

Bull Math Biol. 2018 May;80(5):1195-1206. doi: 10.1007/s11538-017-0279-0. Epub 2017 Jul 5.

PMID:
28681150
14.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL Jr, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.

PMID:
28596256
15.

Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases.

Ahmed KA, Kim S, Arrington J, Naghavi AO, Dilling TJ, Creelan BC, Antonia SJ, Caudell JJ, Harrison LB, Sahebjam S, Gray JE, Etame AB, Johnstone PA, Yu M, Perez BA.

J Neurooncol. 2017 Jun;133(2):331-338. doi: 10.1007/s11060-017-2437-5. Epub 2017 May 2.

PMID:
28466250
16.

The future of personalised radiotherapy for head and neck cancer.

Caudell JJ, Torres-Roca JF, Gillies RJ, Enderling H, Kim S, Rishi A, Moros EG, Harrison LB.

Lancet Oncol. 2017 May;18(5):e266-e273. doi: 10.1016/S1470-2045(17)30252-8. Epub 2017 Apr 26. Review.

PMID:
28456586
17.

Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma.

Strom T, Torres-Roca JF, Parekh A, Naghavi AO, Caudell JJ, Oliver DE, Messina JL, Khushalani NI, Zager JS, Sarnaik A, Mulé JJ, Trotti AM, Eschrich SA, Sondak VK, Harrison LB.

J Natl Compr Canc Netw. 2017 Apr;15(4):473-482.

PMID:
28404758
18.

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.

Scott JG, Berglund A, Schell MJ, Mihaylov I, Fulp WJ, Yue B, Welsh E, Caudell JJ, Ahmed K, Strom TS, Mellon E, Venkat P, Johnstone P, Foekens J, Lee J, Moros E, Dalton WS, Eschrich SA, McLeod H, Harrison LB, Torres-Roca JF.

Lancet Oncol. 2017 Feb;18(2):202-211. doi: 10.1016/S1470-2045(16)30648-9. Epub 2016 Dec 18. Erratum in: Lancet Oncol. 2017 Feb;18(2):e65.

PMID:
27993569
19.

Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas.

Mifsud MJ, Tanvetyanon T, Mccaffrey JC, Otto KJ, Padhya TA, Kish J, Trotti AM, Harrison LB, Caudell JJ.

Head Neck. 2016 Nov;38(11):1628-1633. doi: 10.1002/hed.24484. Epub 2016 Apr 21.

PMID:
27098984
20.

Increased acute mortality with chemoradiotherapy for locally advanced head and neck cancer in patients ≥70years.

Strom TJ, Naghavi AO, Trotti AM, Russell J, Kish JA, McCaffrey J, Otto KJ, Harrison LB, Caudell JJ.

J Geriatr Oncol. 2017 Jan;8(1):50-55. doi: 10.1016/j.jgo.2016.09.003. Epub 2016 Oct 3.

PMID:
27720129
21.

Treatment delays, race, and outcomes in head and neck cancer.

Naghavi AO, Echevarria MI, Strom TJ, Abuodeh YA, Ahmed KA, Venkat PS, Trotti A, Harrison LB, Green BL, Yamoah K, Caudell JJ.

Cancer Epidemiol. 2016 Dec;45:18-25. doi: 10.1016/j.canep.2016.09.005. Epub 2016 Sep 22.

PMID:
27664388
22.

Management of BCC and SCC of the Head and Neck.

Strom TJ, Caudell JJ, Harrison LB.

Cancer Control. 2016 Jul;23(3):220-7. Review.

PMID:
27556662
23.

Management of Oropharyngeal Cancer in the HPV Era.

Naghavi AO, Strom TJ, Ahmed KA, Echevarria MI, Abuodeh YA, Venkat PS, Frakes JM, Harrison LB, Trotti AM, Caudell JJ.

Cancer Control. 2016 Jul;23(3):197-207. Review.

PMID:
27556659
24.

Maximizing Cures and Preserving Function in Head and Neck Cancers.

Harrison LB, Caudell JJ.

Cancer Control. 2016 Jul;23(3):192. No abstract available.

PMID:
27556658
25.

Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies.

Naghavi AO, Echevarria MI, Grass GD, Strom TJ, Abuodeh YA, Ahmed KA, Kim Y, Trotti AM, Harrison LB, Yamoah K, Caudell JJ.

Cancer. 2016 Nov 15;122(22):3529-3537. doi: 10.1002/cncr.30212. Epub 2016 Aug 1.

26.

Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy.

Ahmed KA, Caudell JJ, El-Haddad G, Berglund AE, Welsh EA, Yue B, Hoffe SE, Naghavi AO, Abuodeh YA, Frakes JM, Eschrich SA, Torres-Roca JF.

Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1399-1404. doi: 10.1016/j.ijrobp.2016.03.050. Epub 2016 Apr 8.

PMID:
27319288
27.

Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck.

Strom T, Naghavi AO, Messina JL, Kim S, Torres-Roca JF, Russell J, Sondak VK, Padhya TA, Trotti AM, Caudell JJ, Harrison LB.

Head Neck. 2017 Jan;39(1):48-55. doi: 10.1002/hed.24527. Epub 2016 Jun 14.

PMID:
27300153
28.

Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma.

Strom T, Carr M, Zager JS, Naghavi A, Smith FO, Cruse CW, Messina JL, Russell J, Rao NG, Fulp W, Kim S, Torres-Roca JF, Padhya TA, Sondak VK, Trotti AM, Harrison LB, Caudell JJ.

Ann Surg Oncol. 2016 Oct;23(11):3572-3578. doi: 10.1245/s10434-016-5293-1. Epub 2016 Jun 1.

PMID:
27251134
29.

Stereotactic Body Radiotherapy for Recurrent Unresectable Head and Neck Cancers.

Strom T, Wishka C, Caudell JJ.

Cancer Control. 2016 Jan;23(1):6-11. Review.

PMID:
27009451
30.

Outcomes of mucosal melanoma of the head and neck.

Frakes JM, Strom TJ, Naghavi AO, Trotti A, Rao NG, McCaffrey JC, Otto KJ, Padhya T, Caudell JJ.

J Med Imaging Radiat Oncol. 2016 Apr;60(2):268-73. doi: 10.1111/1754-9485.12404. Epub 2015 Nov 23.

PMID:
26597431
31.

Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.

Frakes JM, Naghavi AO, Demetriou SK, Strom TJ, Russell JS, Kish JA, McCaffrey JC, Otto KJ, Padhya TA, Harrison LB, Trotti AM, Caudell JJ.

Cancer. 2016 Feb 15;122(4):634-41. doi: 10.1002/cncr.29782. Epub 2015 Nov 13.

32.

Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.

Torres-Roca JF, Fulp WJ, Caudell JJ, Servant N, Bollet MA, van de Vijver M, Naghavi AO, Harris EE, Eschrich SA.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):631-8. doi: 10.1016/j.ijrobp.2015.06.021. Epub 2015 Jun 25.

33.

The radiosensitivity index predicts for overall survival in glioblastoma.

Ahmed KA, Chinnaiyan P, Fulp WJ, Eschrich S, Torres-Roca JF, Caudell JJ.

Oncotarget. 2015 Oct 27;6(33):34414-22. doi: 10.18632/oncotarget.5437.

34.

Head and Neck Cancers, Version 1.2015.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M.

J Natl Compr Canc Netw. 2015 Jul;13(7):847-55; quiz 856.

35.

Comparison of every 3 week cisplatin or weekly cetuximab with concurrent radiotherapy for locally advanced head and neck cancer.

Strom TJ, Trotti AM, Kish J, Russell JS, Rao NG, McCaffrey J, Padhya TA, Otto KJ, Caudell JJ.

Oral Oncol. 2015 Jul;51(7):704-8. doi: 10.1016/j.oraloncology.2015.04.012. Epub 2015 Apr 30.

PMID:
25936651
36.

Altered fractionation schedules in radiation treatment: a review.

Ahmed KA, Correa CR, Dilling TJ, Rao NG, Shridhar R, Trotti AM, Wilder RB, Caudell JJ.

Semin Oncol. 2014 Dec;41(6):730-50. doi: 10.1053/j.seminoncol.2014.09.012. Epub 2014 Oct 6. Review.

PMID:
25499633
37.

Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Oct;12(10):1454-87.

38.

Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer.

Rao NG, Trotti A, Kim J, Schell MJ, Zhao X, Amdur RJ, Brizel DM, Chambers MS, Caudell JJ, Miyamoto C, Rosenthal DI.

Oral Oncol. 2014 Aug;50(8):765-9. doi: 10.1016/j.oraloncology.2014.06.001. Epub 2014 Jun 20.

39.

Effect of prophylactic fluconazole on oral mucositis and candidiasis during radiation therapy for head-and-neck cancer.

Rao NG, Han G, Greene JN, Tanvetyanon T, Kish JA, De Conti RC, Chuong MD, Shridhar R, Biagioli MC, Caudell JJ, Trotti AM 3rd.

Pract Radiat Oncol. 2013 Jul-Sep;3(3):229-233. doi: 10.1016/j.prro.2012.05.008. Epub 2012 Jun 21.

PMID:
24674369
40.

Radiotherapy influences local control in patients with desmoplastic melanoma.

Strom T, Caudell JJ, Han D, Zager JS, Yu D, Cruse CW, Marzban SS, Messina JL, Trotti AM, Sondak VK, Rao NG.

Cancer. 2014 May 1;120(9):1369-78. doi: 10.1002/cncr.28412. Epub 2013 Oct 18.

41.

Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal cancer.

Strom T, Trotti AM, Kish J, Rao NG, McCaffrey J, Padhya TA, Lin HY, Fulp W, Caudell JJ.

JAMA Otolaryngol Head Neck Surg. 2013 Nov;139(11):1242-6. doi: 10.1001/jamaoto.2013.5193.

PMID:
24136493
42.

Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.

Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 Aug;11(8):917-23. Erratum in: J Natl Compr Canc Netw. 2013 Dec 1;11(12):1458.

PMID:
23946171
43.

Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with induction chemotherapy.

Zhang H, Graham CM, Elci O, Griswold ME, Zhang X, Khan MA, Pitman K, Caudell JJ, Hamilton RD, Ganeshan B, Smith AD.

Radiology. 2013 Dec;269(3):801-9. doi: 10.1148/radiol.13130110. Epub 2013 Oct 28.

PMID:
23912620
44.

Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity-modulated radiotherapy for head and neck cancer.

Batth SS, Caudell JJ, Chen AM.

Head Neck. 2014 Feb;36(2):291-8. doi: 10.1002/hed.23246. Epub 2013 Mar 18. Review.

PMID:
23508721
45.

Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma.

May JT, Rao N, Sabater RD, Boutrid H, Caudell JJ, Merchant F, Han G, Padhya TA, McCaffrey JC, Tanvetyanon T, Deconti R, Kish J, McCaffrey TV, Trotti A.

Head Neck. 2013 Dec;35(12):1796-800. doi: 10.1002/hed.23245. Epub 2013 Mar 6.

PMID:
23468387
46.

Personalized medicine for radiation therapy.

Caudell JJ, Eschrich SA, Torres-Roca JF.

Per Med. 2013 Mar;10(2):107-110. doi: 10.2217/pme.12.120. No abstract available.

47.

Patterns of prophylactic gastrostomy tube placement in head and neck cancer patients: a consideration of the significance of social support and practice variation.

Locher JL, Bonner JA, Carroll WR, Caudell JJ, Allison JJ, Kilgore ML, Ritchie CS, Tajeu GS, Yuan Y, Roth DL.

Laryngoscope. 2013 Aug;123(8):1918-25. doi: 10.1002/lary.24022. Epub 2013 Feb 7.

48.

Intraoperative ultrasound guidance during intracavitary brachytherapy applicator placement in cervical cancer: the University of Alabama at Birmingham experience.

Schaner PE, Caudell JJ, De Los Santos JF, Spencer SA, Shen S, Kim RY.

Int J Gynecol Cancer. 2013 Mar;23(3):559-66. doi: 10.1097/IGC.0b013e3182859302.

PMID:
23385283
49.

Induction docetaxel, Cisplatin, and 5-Fluorouracil precludes definitive chemoradiotherapy in a substantial proportion of patients with head and neck cancer in a low socioeconomic status population.

Caudell JJ, Hamilton RD, Otto KJ, Jennelle RL, Pitman KT, Vijayakumar S.

Am J Clin Oncol. 2014 Aug;37(4):332-6. doi: 10.1097/COC.0b013e31827a7cff.

PMID:
23275276
50.

Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies.

Wagner MM, Curé JK, Caudell JJ, Spencer SA, Nabell LM, Carroll WR, Bonner JA.

Radiat Oncol. 2012 Dec 21;7:219. doi: 10.1186/1748-717X-7-219.

Supplemental Content

Loading ...
Support Center